282 related articles for article (PubMed ID: 10261481)
1. Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule.
Fed Regist; 1983 Jun; 48(125):29713-4. PubMed ID: 10261481
[TBL] [Abstract][Full Text] [Related]
2. Dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration. Notice of proposed rulemaking.
Fed Regist; 1982 Sep; 47(181):41140. PubMed ID: 10262071
[TBL] [Abstract][Full Text] [Related]
3. Prescriptions for Schedule II controlled substances: Drug Enforcement Administration, Justice. Notice of proposed rulemaking.
Fed Regist; 1980 Apr; 45(70):24199-200. PubMed ID: 10246081
[TBL] [Abstract][Full Text] [Related]
4. DEA issues proposed rule on e-prescribing.
Ball FR
J Med Pract Manage; 2009; 24(4):243. PubMed ID: 19288650
[TBL] [Abstract][Full Text] [Related]
5. Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2008 May; 73(100):29685-8. PubMed ID: 18605404
[TBL] [Abstract][Full Text] [Related]
6. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
[TBL] [Abstract][Full Text] [Related]
7. Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
Fed Regist; 1991 Jun; 56(106):25025-7. PubMed ID: 10111144
[TBL] [Abstract][Full Text] [Related]
8. Facsimile transmission of prescriptions for patients enrolled in hospice programs. Drug Enforcement Administration (DEA), Justice. Final rule.
Fed Regist; 2001 Jan; 66(8):2214-5. PubMed ID: 11503757
[TBL] [Abstract][Full Text] [Related]
9. The regulatory process: impacting the NP's role.
Wysocki S
Nurse Pract Forum; 1992 Jun; 3(2):56-7. PubMed ID: 1392671
[TBL] [Abstract][Full Text] [Related]
10. Allowing central fill pharmacies and retail pharmacies to fill prescriptions for controlled substances on behalf of retail pharmacies. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 Jun; 68(121):37405-11. PubMed ID: 12836645
[TBL] [Abstract][Full Text] [Related]
11. Placement of gamma-butyrolactone in List I of the Controlled Substances Act (21 U.S.C. 802(34)). Drug Enforcement Administration, Justice. Final rule.
Fed Regist; 2000 Apr; 65(79):21645-7. PubMed ID: 11010670
[TBL] [Abstract][Full Text] [Related]
12. The federal Drug Enforcement Administration "prescription series" proposal: continuing concerns.
Gilson AM; Joranson DE
J Pain Palliat Care Pharmacother; 2007; 21(4):21-4. PubMed ID: 18032312
[TBL] [Abstract][Full Text] [Related]
13. Controlled substances in long-term care pharmacy: part 2.
Martin CM
Consult Pharm; 2008 Oct; 23(10):742-56. PubMed ID: 19032014
[TBL] [Abstract][Full Text] [Related]
14. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
[TBL] [Abstract][Full Text] [Related]
15. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789
[TBL] [Abstract][Full Text] [Related]
16. Registration and reregistration application fees. Confirmation of final rule, remanded for further notice and comment, and response to comments.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2002 Aug; 67(154):51987-52007. PubMed ID: 12194173
[TBL] [Abstract][Full Text] [Related]
17. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Mar; 75(43):10168-72. PubMed ID: 20383917
[TBL] [Abstract][Full Text] [Related]
18. Drug Enforcement Administration--controlled substances in emergency kits for long term care facilities. Statement of policy.
Fed Regist; 1980 Apr; 45(70):24128. PubMed ID: 10246080
[TBL] [Abstract][Full Text] [Related]
19. New Drug Enforcement Administration guideline for communicating controlled substance prescriptions to pharmacies.
Drug Enforcement Adminstration U S Department of Justice
J Pain Palliat Care Pharmacother; 2011; 25(1):83-9. PubMed ID: 21426229
[TBL] [Abstract][Full Text] [Related]
20. Exemption from import/export requirements for personal medical use. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2004 Sep; 69(177):55343-7. PubMed ID: 15366181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
